Welcome to BioNome, Subsidiary of SRNOME Pvt Ltd

Integrating Genomics, Proteomics, and Transcriptomics for Target Discovery in Bangalore

  • Home
  • blog
  • Integrating Genomics, Proteomics, and Transcriptomics for Target Discovery in Bangalore

The integration of genomics, proteomics, and transcriptomics—collectively known as multi-omics analysis—has revolutionized modern drug discovery and precision medicine. In Bangalore, a rapidly growing biotechnology hub, multi-omics approaches are accelerating the identification of novel and reliable therapeutic targets for complex diseases such as cancer, neurological disorders, metabolic conditions, and infectious diseases.
Genomics provides insights into DNA-level variations, including mutations, SNPs, copy number variations, and structural changes that may drive disease progression. Whole genome sequencing and NGS data analysis help identify disease-associated genes and potential molecular targets. However, genomic data alone cannot fully explain how genes are functionally expressed.
This is where transcriptomics plays a crucial role. RNA-Seq analysis reveals gene expression patterns under specific disease conditions, helping researchers understand which genes are actively transcribed and dysregulated. Differential gene expression analysis and pathway enrichment studies highlight critical signaling pathways involved in disease mechanisms.
Proteomics adds another essential layer by analyzing protein expression, post-translational modifications, and protein–protein interactions. Since proteins are the actual functional molecules in cells and primary drug targets, proteomics validation ensures that predicted genomic and transcriptomic targets are biologically relevant.
By integrating these three data layers through advanced bioinformatics tools, systems biology approaches, and network-based analysis, researchers can identify high-confidence drug targets with greater accuracy. Multi-omics integration reduces false positives, improves biomarker discovery, and enhances therapeutic precision.
Recognized as the Best Bioinformatics service provider in Hennur (Karnataka), BioNome offers comprehensive multi-omics data integration services in Bangalore. Our expertise includes NGS data analysis, RNA-Seq analysis, protein interaction network modeling, pathway analysis, disease-specific target prediction, molecular docking, and AI-driven drug discovery solutions. We are committed to delivering affordable bioinformatics services to pharmaceutical companies, biotech firms, academic researchers, and healthcare innovators across India.
By combining genomics, transcriptomics, and proteomics with advanced computational biology and precision medicine strategies, BioNome helps accelerate drug discovery pipelines and improve target validation efficiency.
Contact Details
For integrated multi-omics target discovery services in Bangalore:
📞 +91 8668470445
📧 info@bionome.in
Partner with BioNome to unlock the full potential of multi-omics research for innovative and cost-effective drug discovery solutions.